Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment...
CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment...
RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCEParsortix-based HER2 kit being developed...
Learn How at an Exclusive Webinar on Nov. 20th Hosted by Medical Economics and SpecialdocsĀ CHICAGO, Nov. 14, 2024 /PRNewswire/...